Cargando…

Correction to: Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment

Detalles Bibliográficos
Autores principales:	Keshavarz, Mohsen, Ebrahimzadeh, Mir Saeed, Miri, Seyed Mohammad, Dianat-Moghadam, Hassan, Ghorbanhosseini, Seyedeh Sara, Mohebbi, Seyed Reza, Keyvani, Hossein, Ghaemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664013/ https://www.ncbi.nlm.nih.gov/pubmed/33187531 http://dx.doi.org/10.1186/s12985-020-01444-5

Ejemplares similares

Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
por: Keshavarz, Mohsen, et al.
Publicado: (2019)

Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade
por: Miri, Seyed Mohammad, et al.
Publicado: (2022)

Correction to: Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches
por: Sabbaghi, Ailar, et al.
Publicado: (2020)

Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
por: Koushki, Khadijeh, et al.
Publicado: (2021)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent
por: Samadi, Mehdi, et al.
Publicado: (2022)

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
por: DePeaux, Kristin, et al.
Publicado: (2023)

A Survey on Human T-cell Lymphotropic Virus Type 1 (HTLV-1) and Xenotropic Murine Leukemia Virus-Related Virus (XMRV) Coinfection in Tehran, Iran
por: Keshavarz, Mohsen, et al.
Publicado: (2018)

Trends in surveillance data of influenza virus in Tehran before decreasing dispatch of Iranian Hajj pilgrims to Mecca
por: Esghaei, Maryam, et al.
Publicado: (2018)

Human rotavirus in Iran; molecular epidemiology, genetic diversity and recent updates on vaccine advances
por: Tavakoli Nick, Shadi, et al.
Publicado: (2019)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
por: Fournier, Philippe, et al.
Publicado: (2013)

Therapeutic potential of oncolytic Newcastle disease virus: a critical review
por: Tayeb, Shay, et al.
Publicado: (2015)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Oncolytic viruses: finally delivering
por: Seymour, Leonard W, et al.
Publicado: (2016)

Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
por: Kadhim, Zahraa A., et al.
Publicado: (2022)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
por: Mahooti, Mehran, et al.
Publicado: (2020)

Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
por: Yurchenko, K. S., et al.
Publicado: (2019)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
por: Shoraka, Shahrzad, et al.
Publicado: (2021)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
por: Franco-Luzón, Lidia, et al.
Publicado: (2020)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
por: Schirrmacher, Volker, et al.
Publicado: (2019)

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
por: Schirrmacher, Volker
Publicado: (2022)

Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
por: Numpadit, Supaporn, et al.
Publicado: (2023)

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
por: Akram, Sura, et al.
Publicado: (2023)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ifn2f0rj5oupt7lvb3hq2bs310